Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1983 1
1990 2
1991 1
1992 1
1994 4
1995 2
1996 1
1997 1
1998 1
1999 5
2000 3
2001 2
2002 2
2003 3
2004 3
2005 4
2006 2
2007 6
2008 3
2009 13
2010 8
2011 11
2012 13
2013 16
2014 10
2015 14
2016 15
2017 7
2018 10
2019 6
2020 19
2021 9
2022 15
2023 24
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Premature ovarian failure 9"
Page 1
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. Grundy SM, et al. Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10. Circulation. 2019. PMID: 30586774 Free PMC article.
Risk-enhancing factors include family history of premature ASCVD; persistently elevated LDL-C levels 160 mg/dL (4.1 mmol/L); metabolic syndrome; chronic kidney disease; history of preeclampsia or premature menopause (age <40 years); chronic inflammatory di …
Risk-enhancing factors include family history of premature ASCVD; persistently elevated LDL-C levels 160 mg/dL (4.1 mmol/L); metaboli …
Genetics of primary ovarian insufficiency: new developments and opportunities.
Qin Y, Jiao X, Simpson JL, Chen ZJ. Qin Y, et al. Hum Reprod Update. 2015 Nov-Dec;21(6):787-808. doi: 10.1093/humupd/dmv036. Epub 2015 Aug 4. Hum Reprod Update. 2015. PMID: 26243799 Free PMC article. Review.
BACKGROUND: Primary ovarian insufficiency (POI) is characterized by marked heterogeneity, but with a significant genetic contribution. ...Whole genome approaches have utilized genome-wide association studies (GWAS) to reveal loci not predicted on the basis of a cand …
BACKGROUND: Primary ovarian insufficiency (POI) is characterized by marked heterogeneity, but with a significant genetic contribution …
The Role of Arachidonic and Linoleic Acid Derivatives in Pathological Pregnancies and the Human Reproduction Process.
Szczuko M, Kikut J, Komorniak N, Bilicki J, Celewicz Z, Ziętek M. Szczuko M, et al. Int J Mol Sci. 2020 Dec 17;21(24):9628. doi: 10.3390/ijms21249628. Int J Mol Sci. 2020. PMID: 33348841 Free PMC article. Review.
In addition, cyclooxygenase-mediated prostaglandins and AA metabolite levels are higher in women's ovarian tissue when suffering from PCOS. It has been demonstrated that abnormal cyclooxygenase-2 (COX-2) levels are associated with ovulation failure, infertility, and …
In addition, cyclooxygenase-mediated prostaglandins and AA metabolite levels are higher in women's ovarian tissue when suffering from …
Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals.
Hu YY, Zhong RH, Guo XJ, Li GT, Zhou JY, Yang WJ, Ren BT, Zhu Y. Hu YY, et al. J Ethnopharmacol. 2023 May 10;307:116242. doi: 10.1016/j.jep.2023.116242. Epub 2023 Feb 10. J Ethnopharmacol. 2023. PMID: 36775079
The formula is clinically used to regulate menstrual cycle and alleviate polycystic ovarian syndrome due to its capabilities of ovulation induction. It is therefore presumed that JFP could be used for the therapy of premature ovarian insufficiency (POI) but t …
The formula is clinically used to regulate menstrual cycle and alleviate polycystic ovarian syndrome due to its capabilities of ovula …
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.
Lambertini M, Boni L, Michelotti A, Magnolfi E, Cogoni AA, Mosconi AM, Giordano M, Garrone O, Arpino G, Poggio F, Cinacchi P, Bighin C, Fregatti P, Pronzato P, Blondeaux E, Del Mastro L; GIM study group. Lambertini M, et al. J Natl Cancer Inst. 2022 Mar 8;114(3):400-408. doi: 10.1093/jnci/djab213. J Natl Cancer Inst. 2022. PMID: 34850043 Free PMC article. Clinical Trial.
The primary planned endpoint was incidence of chemotherapy-induced premature ovarian insufficiency. Post hoc endpoints were disease-free survival (DFS), overall survival (OS), and post-treatment pregnancies. ...In the GnRHa and control arms, 9 and 4 patients …
The primary planned endpoint was incidence of chemotherapy-induced premature ovarian insufficiency. Post hoc endpoints were di …
Mediterranean diet and female reproductive health over lifespan: a systematic review and meta-analysis.
Yang J, Song Y, Gaskins AJ, Li LJ, Huang Z, Eriksson JG, Hu FB, Chong YS, Zhang C. Yang J, et al. Am J Obstet Gynecol. 2023 Dec;229(6):617-631. doi: 10.1016/j.ajog.2023.05.030. Epub 2023 Jul 26. Am J Obstet Gynecol. 2023. PMID: 37506751 Review.
Subgroup analyses were performed for several pregnancy outcomes according to timing of the interventions for randomized controlled trials and timing of the dietary assessment for observational studies. RESULTS: Thirty-two studies (9 randomized controlled trials, 22 …
Subgroup analyses were performed for several pregnancy outcomes according to timing of the interventions for randomized controlled trials an …
Plasma metabolomic characterization of premature ovarian insufficiency.
Zhou XY, Li X, Zhang J, Li Y, Wu XM, Yang YZ, Zhang XF, Ma LZ, Liu YD, Wang Z, Chen SL. Zhou XY, et al. J Ovarian Res. 2023 Jan 5;16(1):2. doi: 10.1186/s13048-022-01085-y. J Ovarian Res. 2023. PMID: 36600288 Free PMC article.
BACKGROUND: Premature ovarian insufficiency (POI) patients are predisposed to metabolic disturbances, including in lipid metabolism and glucose metabolism, and metabolic disorders appear to be a prerequisite of the typical long-term complications of POI, such as car …
BACKGROUND: Premature ovarian insufficiency (POI) patients are predisposed to metabolic disturbances, including in lipid metab …
Dingkun Pill modulate ovarian function in chemotherapy-induced premature ovarian insufficiency mice by regulating PTEN/PI3K/AKT/FOXO3a signaling pathway.
Su C, Zhang R, Zhang X, Lv M, Liu X, Ao K, Hao J, Mu YL. Su C, et al. J Ethnopharmacol. 2023 Oct 28;315:116703. doi: 10.1016/j.jep.2023.116703. Epub 2023 May 29. J Ethnopharmacol. 2023. PMID: 37257704 Free article.
AIM OF THE STUDY: To investigate the effect of different doses of Dingkun Pill on ovarian function in cyclophosphamide (CTX)-induced premature ovarian insufficiency (POI) mice and to explore its molecular mechanism through PTEN/PI3K/AKT/FOXO3a signaling pathw …
AIM OF THE STUDY: To investigate the effect of different doses of Dingkun Pill on ovarian function in cyclophosphamide (CTX)-induced …
Red Ginseng Improves D-galactose-Induced Premature Ovarian Failure in Mice Based on Network Pharmacology.
Shang Z, Fan M, Zhang J, Wang Z, Jiang S, Li W. Shang Z, et al. Int J Mol Sci. 2023 May 4;24(9):8210. doi: 10.3390/ijms24098210. Int J Mol Sci. 2023. PMID: 37175917 Free PMC article.
In this study, we evaluated the ameliorative effect and molecular mechanism of red ginseng (Panax ginseng C.A. Meyer) extract (RGE) on D-galactose (D-gal)-induced premature ovarian failure (POF) using network pharmacology analysis. ...Network pharmacology ana …
In this study, we evaluated the ameliorative effect and molecular mechanism of red ginseng (Panax ginseng C.A. Meyer) extract (RGE) on D-gal …
X chromosome and ovarian failure.
Toniolo D, Rizzolio F. Toniolo D, et al. Semin Reprod Med. 2007 Jul;25(4):264-71. doi: 10.1055/s-2007-980220. Semin Reprod Med. 2007. PMID: 17594607 Review.
Here we review the X-linked disorders of ovulation and we show that despite the relatively frequent observation of X chromosome rearrangements in women with ovarian dysgenesis or ovarian failure, the search for X-linked genes has not yet been very frui …
Here we review the X-linked disorders of ovulation and we show that despite the relatively frequent observation of X chromosome rearr …
217 results